10x Insights
Loading account…
FSPHX

Select Health Care Portfolio

Actively managedEquityOpen-end fund
Fidelity Select Portfolios: FSPHX · FHCQX · FHCRX · FHCLX · FHCNX · FHCPXHoldings as of May 31, 2026Filed Jul 24, 2026

Actively managed U.S. stock fund

As of its 2026 Q2 report, Select Health Care Portfolio held 152 positions with $5.78B in net assets. Its ten largest holdings made up 38.8% of the fund. The FSPHX share class costs 0.62% a year. Over the 12 months to May 2026, FSPHX returned 19.5%, with dividends reinvested. In 2026 Q2 it added 39 new positions and exited 22.

2026 Q2 holdings and allocationChanges are against the previous quarter, 2026 Q1Headline fees and returns use the FSPHX share class
Expense ratio · FSPHX
0.62%
$62 a year for every $10,000 invested
0.55% – 1.66% across the 6 classes
$5.78B
The whole fund, all share classes
152 holdings
38.8%in the top 10
Weight held in the ten largest holdings
Top 25 hold 59.6%
Return, 1 year · FSPHX
+19.5%
With dividends, to May 2026
3 yr total +21.9% · 5 yr total +13.2%
What this fund is
Objective, as filed

Health Care Portfolio seeks capital appreciation.

Strategy, summarised

The fund invests at least 80% of assets in common stocks of companies principally engaged in health care and medicine, including biotechnology, pharmaceuticals, medical devices and equipment, and health care facilities and managed plans, using fundamental analysis of financial condition and industry position. The fund may invest in both domestic and foreign issuers. Because the fund's classification of companies as principally engaged in health care depends on factors such as asset levels, income, sales, or profits derived from designated activities, or on third-party industry classifications, the fund's holdings may diverge from what different analysts would consider core health care exposure.

What you own

per cent of the fund
CompanyWeightValue
8.03%
$464.10M
6.89%
$398.22M
4.91%
$283.92M
4.33%
$250.20M
3.49%
$201.56M
2.40%
$138.91M
2.21%
$127.71M
2.17%
$125.61M
ASCENDIS PHARMA A/S
2.17%
$125.50M
Fidelity Revere Street Trust
2.17%
$125.45M
Showing 1–10 of 152 · the top 10 are 38.76% of the fund, the top 25 are 59.59%

Reported price is the fund's own reported value divided by its own reported shares at 2026-05-31 — not a live quote, and not what the fund paid.

All 152 holdings, with the share counts as filed, open with a free account.

What the fund is made of

Percentages are of fund net assets. Rounding, liabilities and short positions can make totals differ from 100%.

102.19%
of net assets
Stocks99.69%
Cash & short-term2.36%
Bonds0.14%

By sector

Health Care
84.9%
International
10.7%
Cash
2.3%
Other
1.9%
1 other sector
0.2%

How it has done

Total return, dividends reinvested · to May 2026

FSPHX share class · total returns with dividends reinvested

1 year
+19.50%
3 years
+21.90%
Cumulative, not per year
5 years
+13.16%
Cumulative, not per year
Largest decline in 3 years
-13.59%
From a previous high to a later low
Cumulative return, last three years· Jun 2023 – May 2026

Volatility over the last 12 months: 13.48%. Past returns are a record, not a forecast.

Fees & fund details

Select Health Care Portfolio is an actively managed U.S. equity fund.

Asset class
Equity
Region
United States
Management
Actively managed
Fund type
Open-end fund
Features
Non-diversified
Expense ratio, by class
0.55% – 1.66%· FSPHX 0.62%
Portfolio turnover
69.00% a year · as of 2026 Q2

Turnover is how much of the portfolio was replaced in a year.

Classified from what the fund holds, not from its name · 2026 Q2. The summary is a paraphrase of the prospectus; the objective is verbatim.

What changed this quarter

2026 Q2 vs 2026 Q1

Positions that entered or left the fund since its previous filing. Positions that were only resized are not listed.

39 new· the largest 8

ASCENDIS PHARMA A/S
JAZZ PHARMACEUTICALS PLC
ROCHE HOLDING AG

22 exited· the largest 8

ASCENDIS PHARMA A/S
ROCHE HOLDING AG
CENTESSA PHARMACEUTICALS PLC
BIONTECH SE

Debt profile

What this fund holds — value-weighted across its bond and securitized long positions · as of 2026-05-31

Avg coupon
0.07%
Avg maturity
0.63 yr
Coupon type

Share of the fund's debt by how its coupon behaves — the fact that decides whether a rate move reaches this portfolio at all.

29%
floating
Fixed rate70.8%
Floating rate29.2%
Maturity ladder

Share of the fund's debt value in each maturity band, shortest first.

<1y10y+
<1y70.8%
10y+29.2%
Flagged holdings
Defaulted: none reported
In arrears: none reported
Paid in kind: none reported

Based on what filers reported; a filer that never reported a flag also reads as none.

Connected research

Understand how this fund fits with the rest.

Explore shared holdings, compare funds and follow their businesses with your connected AI:

  • “Where do my funds overlap — FSPHX, QQQ and the fund in my 401(k)?”
  • “How do this fund’s ten biggest holdings stack up against each other?”
  • “For my target-date fund, what’s the real stock-and-bond mix once you look through it?”
See how it works →All research tools with a subscription. Use your own AI account.